Richard Davies wrote: The UK has a good crop of technology pioneers in cloud computing - for example ElasticHosts, FlexiScale, Flexiant, OnApp - and also some strong government initiatives such as G-Cloud.
We will have to see whether this kind of technical leadership converts into swift mass-market adoption or not.
HONG KONG, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China Cord Blood
Corporation (NYSE: CO; "the Company") today announced its plan to release
financial results for the first quarter of fiscal year 2011 on Friday,
September 10, 2010, before the market opens in the US.
The Company will hold a teleconference at 8:00 a.m. ET on Friday,
September 10, 2010 to discuss its financial performance and give a brief
overview of the Company's recent developments, followed by a question and
answer session. Interested parties may access the audio webcast through the
following link:
http://phx.corporate-ir.net/playerlink.zhtml?c=206671&s=wm&e=3297686 . A
replay of the webcast will be accessible two hours after the presentation and
available for three weeks at the same URL link above. Listeners may also
access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or
+852-2475-0994 for Hong Kong callers, access code: 94640489.
Supplemental financial information referenced in the conference call and
the text of the first quarter press release can be found at
http://www.chinacordbloodcorp.com , in the section titled Investor
Center/Press Release, after 7:00 a.m. ET on the morning of the conference call.
Please dial in ten minutes prior to the conference to ensure proper
connection and be prepared to provide your name and company to the operator.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and the largest cord blood
banking operator in China in terms of geographical coverage and is the only
cord blood bank operator with multiple licenses. Under the current PRC
government regulations, only one licensed cord blood bank operator is
permitted to operate in each licensed region and only six licenses have been
issued as of today. China Cord Blood Corporation provides cord blood
collection, laboratory testing, hematopoietic stem cell processing, and stem
cell storage services. For more information, please visit our website at
http://www.chinacordbloodcorp.com .
For more information, please contact:
China Cord Blood Corporation
Ms. Joeling Law
Tel: +852-3605-8180
Email: ir@chinacordbloodcorp.com
ICR, LLC
In New York:
Ashley M. Ammon or Christine Duan
Tel: +1-646-277-1227
In Beijing:
Wen Lei Zheng
Tel: +86-10-6599-7968